This year, regulators approved the first gene therapy treatment for cancer. Using this landmark treatment, a patient’s own cells are turbo-charged outside the body, reinjected, then used to attack cancer - like tiny, but effective, tumour assassins.
Drug companies are selling tests for thousands of euro that can provide the unique genomic profile of an individual patient’s tumour. The reason? Instead of blasting cancer patients with chemotherapy and radiation that destroy everything in...
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Unlimited Access for 2 Years
Get a Business Account for you and your team